CallSchedule a consultation
The Dagan Edit archive

Treatment spotlight

alloClae brings donor adipose tissue into the body-contouring conversation.

alloClae is a ready-to-use human adipose-tissue allograft intended for localized subcutaneous cushioning and support where fat naturally exists. It avoids a fat-harvest procedure, but it is not a synthetic facial filler, does not contain living cells, and carries tissue-product risks that deserve a careful candidacy and consent discussion.

Editorial adipose-tissue illustration with cells, connective matrix and a vial representing donor adipose-allograft research; not a patient result
Editorial adipose-tissue illustration with cells, connective matrix and a vial representing donor adipose-allograft research; not a patient result

The report, in context

What this development means—and what it does not.

alloClae is a ready-to-use human adipose-tissue allograft intended for localized subcutaneous cushioning and support where fat naturally exists. It avoids a fat-harvest procedure, but it is not a synthetic facial filler, does not contain living cells, and carries tissue-product risks that deserve a careful candidacy and consent discussion.

Related Dagan MD pathways

Continue with the relevant clinical context.

Injectables ReframedCompare tissue allografts with hyaluronic-acid fillers, biostimulators and neuromodulators.Facial Fat TransferUnderstand how a donor-derived product differs from harvesting and transferring your own fat.

Inclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.

Madison Avenue · New York City

Bring the question into a clinical conversation.

A consultation connects general educational context to an individual examination, reasonable options, limitations, and recovery.

Schedule a consultation